This resolution designates July 16, 2025, as "Glioblastoma Awareness Day" to foster greater public understanding of this devastating disease. Glioblastoma is the most common, aggressive, and deadly malignant brain tumor, with an estimated 13,000 new diagnoses and over 10,000 deaths annually in the United States. Patients face a grim prognosis, with a 5-year survival rate of only 6.9 percent, highlighting the urgent need for improved treatments and early detection methods. The resolution calls for increased public awareness, honors those affected, and supports efforts to develop more effective treatments that can improve patient prognosis and quality of life. It emphasizes the critical role of molecular biomarker testing for diagnosis and treatment, and urges a collaborative approach among governmental, private, and nonprofit organizations for brain tumor research. Continued investments in glioblastoma research, including through initiatives like the Glioblastoma Therapeutics Network, are encouraged to accelerate progress toward cures and better patient outcomes.